LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Search

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

30.85 -1.91

Overview

Share price change

24h

Current

Min

30.23

Max

31.43

Key metrics

By Trading Economics

Income

-5.8M

40M

Sales

16M

200M

P/E

Sector Avg

9.461

77.256

EPS

0.92

Profit margin

19.839

Employees

268

EBITDA

3M

59M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+44.24% upside

Market Stats

By TradingEconomics

Market Cap

-353M

1.7B

Previous open

32.76

Previous close

30.85

News Sentiment

By Acuity

50%

50%

174 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 lis 2025, 23:38 UTC

Earnings

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 lis 2025, 23:00 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 lis 2025, 22:19 UTC

Earnings
Major Market Movers

Block Shares Slide After 3Q Results Miss Estimates

6 lis 2025, 21:53 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Sales $476M >WPM

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 lis 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 lis 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 lis 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 lis 2025, 23:15 UTC

Earnings

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 lis 2025, 23:13 UTC

Earnings

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 lis 2025, 23:07 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 lis 2025, 23:07 UTC

Earnings

Suzano 3Q Rev BRL12.2B >SUZ

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 lis 2025, 22:45 UTC

Acquisitions, Mergers, Takeovers

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 lis 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 lis 2025, 22:13 UTC

Earnings

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Sales $632.2M >CENX

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Adj EPS 56c >CENX

6 lis 2025, 21:53 UTC

Earnings

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 lis 2025, 21:52 UTC

Acquisitions, Mergers, Takeovers

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 lis 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 lis 2025, 21:50 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

6 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

44.24% upside

12 Months Forecast

Average 45.22 USD  44.24%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

0

Hold

1

Sell

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Very Strong Bearish Evidence

Sentiment

By Acuity

174 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat